Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Return on Sales (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Return on Sales for 12 consecutive years, with 18.24% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales changed N/A year-over-year to 18.24%, compared with a TTM value of 18.24% through Sep 2025, changed N/A, and an annual FY2024 reading of 19.98%, changed N/A over the prior year.
  • Return on Sales was 18.24% for Q3 2025 at Lisata Therapeutics, up from 18.92% in the prior quarter.
  • Across five years, Return on Sales topped out at 8389.56% in Q2 2023 and bottomed at 19.31% in Q1 2025.
  • Average Return on Sales over 3 years is 1921.53%, with a median of 11.43% recorded in 2024.